Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qilu Pharmaceutical Spain is the Spanish subsidiary of the Qilu Pharmaceutical Group, one of China's leading pharmaceutical enterprises. The company focuses on the development, manufacturing, and global commercialization of a vast portfolio of generic medicines, biosimilars, and innovative new drugs. Its therapeutic expertise spans oncology, anti-infectives, cardiovascular health, and central nervous system disorders. In the Spanish market, the company manages regulatory affairs, market access, and the distribution of high-quality finished dosage forms and active pharmaceutical ingredients. Qilu is recognized for its large-scale GMP-certified manufacturing capabilities and its strategic expansion into European markets to provide affordable healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qilu Pharma Spain.